Cargando…
Safety-Related Drug Withdrawals in China Between 1999 and 2021: A Systematic Investigation and Analysis
INTRODUCTION: The Chinese National Medical Products Administration (NMPA) has emphasized proactive pharmacovigilance throughout the product life cycle in recent years. However, the safety-related withdrawal of drugs from the Chinese market has received less attention. OBJECTIVES: The primary aim of...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296427/ https://www.ncbi.nlm.nih.gov/pubmed/35821561 http://dx.doi.org/10.1007/s40264-022-01185-0 |